The medicalization of chronic disease and costs
- PMID: 22224894
- DOI: 10.1146/annurev-publhealth-031811-124652
The medicalization of chronic disease and costs
Abstract
U.S. health care spending has increased dramatically in the past several decades, consuming 17.6% percent ($2.6 trillion) of GDP in 2010. Although historical spending drivers do not account for this recent increase, two major changes in population health--the rise in obesity and obesity-related chronic disease--provide a likely explanation. This article reviews the contribution that rising treated obesity-related chronic disease prevalence and its associated treatment (spending per treated case) has made to the growth in health care spending. We discuss trends in the clinical incidence of obesity and chronic disease as well as timely advancements in disease detection, treatment, and management. Evidence shows that rising obesity rates are influencing spending largely by increasing the treated prevalence of obesity-related chronic disease. Therefore, preventing individuals from becoming treated cases in the first place is one key way that our country can cut health care spending moving forward.
Similar articles
-
The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011.Appl Health Econ Health Policy. 2015 Aug;13(4):381-7. doi: 10.1007/s40258-015-0164-7. Appl Health Econ Health Policy. 2015. PMID: 25850897
-
Treated disease prevalence and spending per treated case drove most of the growth in health care spending in 1987-2009.Health Aff (Millwood). 2013 May;32(5):851-8. doi: 10.1377/hlthaff.2012.0391. Health Aff (Millwood). 2013. PMID: 23650317
-
Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity.Public Health. 2006 Nov;120(11):1002-7. doi: 10.1016/j.puhe.2006.09.001. Epub 2006 Oct 9. Public Health. 2006. PMID: 17030050
-
The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987-2011.Pharmacoeconomics. 2015 Jul;33(7):691-7. doi: 10.1007/s40273-015-0284-9. Pharmacoeconomics. 2015. PMID: 25943686 Review.
-
The medical costs attributable to meat consumption.Prev Med. 1995 Nov;24(6):646-55. doi: 10.1006/pmed.1995.1100. Prev Med. 1995. PMID: 8610089 Review.
Cited by
-
Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):19-30. doi: 10.1331/JAPhA.2015.14107. J Am Pharm Assoc (2003). 2015. PMID: 25575148 Free PMC article.
-
Phentermine and topiramate for the management of obesity: a review.Drug Des Devel Ther. 2011 Apr 5;7:267-78. doi: 10.2147/DDDT.S31443. Print 2013. Drug Des Devel Ther. 2011. PMID: 23630412 Free PMC article. Review.
-
Future directions of multiple behavior change research.J Behav Med. 2017 Feb;40(1):194-202. doi: 10.1007/s10865-016-9809-8. Epub 2016 Oct 26. J Behav Med. 2017. PMID: 27785652
-
Trends in chronic disease incidence rates from the Canadian Chronic Disease Surveillance System.Health Promot Chronic Dis Prev Can. 2019 Jun;39(6-7):216-224. doi: 10.24095/hpcdp.39.6/7.02. Health Promot Chronic Dis Prev Can. 2019. PMID: 31210047 Free PMC article.
-
Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1618-1625. doi: 10.1007/s00259-018-4002-7. Epub 2018 Apr 7. Eur J Nucl Med Mol Imaging. 2018. PMID: 29627935
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous